サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1414625

徐放性賦形剤の世界市場レポート 2024年

Sustained Release Excipients Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
徐放性賦形剤の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

徐放性賦形剤の市場規模は近年力強く成長しています。2023年の12億9,000万米ドルから2024年には14億1,000万米ドルへと、CAGR9.6％で拡大します。歴史的な期間に見られた成長は、薬物放出制御に対する需要の高まり、慢性疾患の流行、患者のコンプライアンスと利便性の重視、製薬業界の技術革新、徐放性製剤に対する規制当局の支援に起因しています。

徐放性賦形剤市場規模は、今後数年間で力強い成長が見込まれます。2028年にはCAGR8.4％で19億6,000万米ドルに成長します。予測期間中に予想される成長は、高齢者人口の増加、個別化医療への注目の高まり、患者の服薬アドヒアランスに関する課題、複雑な製剤の増加、疾病管理の進歩、ヘルスケアの世界の拡大に起因しています。予測期間中に予想される主な動向としては、患者中心のドラッグデリバリーへのシフト、製剤開発のための共同作業、規制遵守と安全性の重視、製剤技術の世界的拡大、バイオ医薬品の影響力の増大などが挙げられます。

徐放性賦形剤市場の成長が期待される背景には、慢性疾患と急性疾患の有病率の増加があります。慢性疾患は3カ月以上続く持続的な症状であるのに対し、急性疾患は発症が早く持続期間が短いです。徐放性賦形剤は、慢性疾患と急性疾患の両方に対応する医薬品の製剤化に利用され、患者の服薬アドヒアランスを高め、薬物レベルを一定に保ち、副作用を軽減し、疾患管理を改善します。例えば、2022年9月に世界保健機関（WHO）が報告したように、心血管疾患、慢性呼吸器疾患、糖尿病、がんは非伝染性疾患による死亡の大きな原因となっています。さらに、2022年10月の汎米保健機構によれば、結核患者は2021年に4.5％増加しました。したがって、慢性および急性疾患の有病率の上昇は、徐放性賦形剤市場の主要な促進要因です。

徐放性賦形剤市場は、個別化医療に対する需要の高まりからも恩恵を受けると予想されます。個別化医療は、精密医療を使用してカスタマイズされた治療を提供するために、個々の遺伝子、タンパク質、および身体成分を研究することを含みます。徐放性賦形剤は、個々の患者のニーズに合わせた薬剤製剤の開発を促進することで、この分野で重要な役割を果たしています。2022年に米国食品医薬品局（FDA）が承認した個別化医薬品は12品目で、新たに承認された治療用分子実体の約34％を占めると、個別化医療連合（Personalized Medicine Coalition）のThe Scope and Significance of Progress in 2022で報告されています。したがって、個別化医療に対する需要の増加は、徐放性賦形剤市場の成長に寄与しています。

北米は2023年の世界の徐放性賦形剤市場において最大の地域でした。アジア太平洋は予測期間中に最も急成長する地域となる見込みです。徐放性賦形剤市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界の徐放性賦形剤市場、製品別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • ゼラチン
  • ポリマー
  • ミネラル
  • 砂糖
  • アルコール
  • キトサン
  • 世界の徐放性賦形剤市場、投与経路別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 経口
  • 筋肉内
  • 皮下
  • 経皮
  • 経膣
  • 眼
  • 静脈内
  • その他
  • 世界の徐放性賦形剤市場、技術別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • ターゲットデリバリー
  • マイクロカプセル化
  • ウルスターテクニック
  • 経皮
  • インプラント
  • コアセルベーション

第7章 地域および国の分析

  • 世界の徐放性賦形剤市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界の徐放性賦形剤市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 徐放性賦形剤市場の競合情勢
  • 徐放性賦形剤市場の企業プロファイル
    • Mylan NV
    • Pfizer Inc.
    • Sun Pharmaceutical Industries Ltd.
    • Novartis AG
    • Ashland Global Holdings

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の見通しと可能性の分析

第35章 付録

目次
Product Code: r12135

“Sustained Release Excipients Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on sustained release excipients market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for sustained release excipients? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The sustained release excipients market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Product: Gelatin; Polymers; Minerals; Sugars; Alcohol; Chitosan
  • 2) By Route of Administration: Oral; Intramuscular; Subcutaneous; Transdermal; Vaginal; Ophthalmic; Intravenous; Other Routes of Administration
  • 3) By Technology: Targeted Delivery; Micro Encapsulation; Wurster Technique; Transdermal; Implants; Coacervation
  • Companies Mentioned: Mylan N.V.; Pfizer Inc.; Sun Pharmaceutical Industries Ltd.; Novartis AG; Ashland Global Holdings
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Sustained-release excipients are pharmaceutical ingredients or additives utilized in formulating drug delivery systems with the aim of achieving controlled or sustained release of active pharmaceutical ingredients (APIs) over an extended period. These excipients play a critical role in regulating the release rate and duration of drug action, optimizing therapeutic efficacy, and enhancing patient compliance.

The primary types of sustained-release excipient products encompass gelatin, polymers, minerals, sugars, alcohol, and chitosan. Gelatin, a protein derived from collagen, the most abundant protein in animal connective tissues such as skin, bones, and tendons, is administered through various routes such as oral, intramuscular, subcutaneous, transdermal, vaginal, ophthalmic, intravenous, and others. Various technologies are employed, including targeted delivery, microencapsulation, the Wurster technique, transdermal delivery, implants, and coacervation.

The sustained release excipients market research report is one of a series of new reports from The Business Research Company that provides sustained release excipients market statistics, including sustained release excipients industry global market size, regional shares, competitors with a sustained release excipients market share, detailed sustained release excipients market segments, market trends and opportunities, and any further data you may need to thrive in the sustained release excipients industry. This sustained release excipients market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The sustained release excipients market size has grown strongly in recent years. It will grow from $1.29 billion in 2023 to $1.41 billion in 2024 at a compound annual growth rate (CAGR) of 9.6%. The growth witnessed in the historic period can be attributed to a heightened demand for controlled drug release, the prevalence of chronic diseases, emphasis on patient compliance and convenience, innovations in the pharmaceutical industry, and regulatory support for extended-release formulations.

The sustained release excipients market size is expected to see strong growth in the next few years. It will grow to $1.96 billion in 2028 at a compound annual growth rate (CAGR) of 8.4%. The anticipated growth in the forecast period can be attributed to the rise in the geriatric population, a heightened focus on personalized medicine, challenges related to patient adherence, an increase in complex drug formulations, advancements in disease management, and the global expansion of healthcare. Major trends expected in the forecast period include a shift towards patient-centric drug delivery, collaborative efforts for formulation development, emphasis on regulatory compliance and safety, the global expansion of drug formulation technologies, and the growing influence of biopharmaceuticals.

The anticipated growth of the sustained-release excipients market is attributed to the increasing prevalence of chronic and acute diseases. Chronic diseases are persistent conditions lasting three months or more, while acute diseases have a rapid onset and short duration. Sustained-release excipients are utilized in formulating pharmaceutical products for both chronic and acute diseases, enhancing patient adherence, maintaining consistent drug levels, reducing side effects, and improving disease management. For example, cardiovascular diseases, chronic respiratory illnesses, diabetes, and cancer are significant contributors to non-communicable disease deaths, as reported by the World Health Organization in September 2022. Additionally, tuberculosis cases increased by 4.5% in 2021, according to the Pan American Health Organization in October 2022. Hence, the rising prevalence of chronic and acute diseases is a key driver for the sustained-release excipients market.

The sustained-release excipients market is also expected to benefit from the growing demand for personalized medicine. Personalized medicine involves studying individual genes, proteins, and bodily components to provide customized care using precision medicine. Sustained-release excipients play a crucial role in this field by facilitating the development of drug formulations tailored to individual patient needs. In 2022, the US Food and Drug Administration (FDA) approved 12 personalized medicines, accounting for approximately 34% of all newly approved therapeutic molecular entities, as reported by The Scope and Significance of Progress in 2022 by the Personalized Medicine Coalition. Therefore, the increasing demand for personalized medicine contributes to the growth of the sustained-release excipients market.

The sustained-release excipients market is witnessing a significant trend of product innovation. Major companies in this market are actively engaged in developing innovative products to enhance their market position. For instance, in September 2022, Nutriventia Limited, an India-based pharmaceutical company, introduced Prolanza, a sustained-release ashwagandha ingredient (Withania somnifera). Prolanza, an advanced Ashwagandha root-only extract, provides continuous stress-reduction support with a unique release mechanism, allowing therapeutic effects over an extended period with a once-daily dose. This sustained-release profile was demonstrated through better relative absorption, improved bioavailability, and a longer elimination half-life compared to the control component. Manufactured from natural herbs, Prolanza has been clinically proven to be effective.

Major companies in the sustained-release excipients market are directing their efforts toward technological innovations, including direct compression solutions, to gain a competitive advantage. Direct compression is an efficient tablet manufacturing process involving the direct conversion of a blend of active pharmaceutical ingredients (APIs) and excipients into tablets without additional steps such as granulation or wet massing. For example, in October 2022, Roquette Freres, a France-based provider of plant-based ingredients, introduced PEARLITOL CR-H and PEARLITOL 200 GT for direct compression. PEARLITOL CR-H, a patented blend of mannitol and hydroxypropyl methylcellulose (HPMC), allows sustained release of APIs in direct compression formulations. PEARLITOL 200 GT, a granulated form of mannitol, enhances the flowability and tabletability of direct compression formulations.

In December 2021, Pfizer Inc., a US-based pharmaceutical and biotechnology corporation, acquired Arena Pharmaceuticals for approximately $6.7 billion. This acquisition strengthens Pfizer's capabilities and expertise in inflammation and immunology, further advancing its ability to develop effective treatments for patients with immuno-inflammatory conditions. Arena Pharmaceuticals is a US-based producer of sustained-release drug formulations.

Major companies operating in the sustained release excipients market report are Mylan N.V., Pfizer Inc., Sun Pharmaceutical Industries Ltd., Novartis AG, Ashland Global Holdings, Salix Pharmaceuticals, Allergan PLC, AstraZeneca, GlaxoSmithKline PLC, Mayne Pharma Group Limited, BASF Aktiengesellschaft, International Flavors & Fragrances Inc., Croda International Plc, Gattefosse SAS, Merck KGaA, Food Machinery and Chemical Corporation, Roquette Freres, Colorcon Inc., Dow Chemical Company, Wacker Chemie AG, Evonik Industries Inc., Lubrizol Corporation, Shin-Etsu Chemical Co. Ltd., Eastman Chemical Company, Kerry Group plc, Innophos Holdings Inc., Sensient Technologies Corporation, Koninklijke DSM N.V., Ingredion Incorporated, Cargill Incorporated, Archer Daniels Midland Company, DuPont de Nemours Inc., Lonza Group

North America was the largest region in the global sustained release excipients market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sustained release excipients market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the sustained release excipients market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The sustained-release excipients market consists of sales of ethyl cellulose, lipid-based excipients, waxes, fatty acids, polyethylene glycol (PEG), copovidone, and osmotic agents. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Sustained Release Excipients Market Characteristics

3. Sustained Release Excipients Market Trends And Strategies

4. Sustained Release Excipients Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On the Market
  • 4.2. Ukraine-Russia War Impact On the Market
  • 4.3. COVID-19 Impact On the Market

5. Global Sustained Release Excipients Market Size and Growth

  • 5.1. Global Sustained Release Excipients Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Sustained Release Excipients Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Sustained Release Excipients Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Sustained Release Excipients Market Segmentation

  • 6.1. Global Sustained Release Excipients Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Gelatin
  • Polymers
  • Minerals
  • Sugars
  • Alcohol
  • Chitosan
  • 6.2. Global Sustained Release Excipients Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oral
  • Intramuscular
  • Subcutaneous
  • Transdermal
  • Vaginal
  • Ophthalmic
  • Intravenous
  • Other Routes of Administration
  • 6.3. Global Sustained Release Excipients Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Targeted Delivery
  • Micro Encapsulation
  • Wurster Technique
  • Transdermal
  • Implants
  • Coacervation

7. Sustained Release Excipients Market Regional And Country Analysis

  • 7.1. Global Sustained Release Excipients Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Sustained Release Excipients Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Sustained Release Excipients Market

  • 8.1. Asia-Pacific Sustained Release Excipients Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Sustained Release Excipients Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Sustained Release Excipients Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Sustained Release Excipients Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Sustained Release Excipients Market

  • 9.1. China Sustained Release Excipients Market Overview
  • 9.2. China Sustained Release Excipients Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Sustained Release Excipients Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Sustained Release Excipients Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Sustained Release Excipients Market

  • 10.1. India Sustained Release Excipients Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Sustained Release Excipients Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Sustained Release Excipients Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Sustained Release Excipients Market

  • 11.1. Japan Sustained Release Excipients Market Overview
  • 11.2. Japan Sustained Release Excipients Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Sustained Release Excipients Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Sustained Release Excipients Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Sustained Release Excipients Market

  • 12.1. Australia Sustained Release Excipients Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Sustained Release Excipients Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Sustained Release Excipients Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Sustained Release Excipients Market

  • 13.1. Indonesia Sustained Release Excipients Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Sustained Release Excipients Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Sustained Release Excipients Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Sustained Release Excipients Market

  • 14.1. South Korea Sustained Release Excipients Market Overview
  • 14.2. South Korea Sustained Release Excipients Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Sustained Release Excipients Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Sustained Release Excipients Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Sustained Release Excipients Market

  • 15.1. Western Europe Sustained Release Excipients Market Overview
  • 15.2. Western Europe Sustained Release Excipients Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Sustained Release Excipients Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Sustained Release Excipients Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Sustained Release Excipients Market

  • 16.1. UK Sustained Release Excipients Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Sustained Release Excipients Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Sustained Release Excipients Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Sustained Release Excipients Market

  • 17.1. Germany Sustained Release Excipients Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Sustained Release Excipients Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Sustained Release Excipients Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Sustained Release Excipients Market

  • 18.1. France Sustained Release Excipients Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Sustained Release Excipients Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Sustained Release Excipients Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Sustained Release Excipients Market

  • 19.1. Italy Sustained Release Excipients Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Sustained Release Excipients Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Sustained Release Excipients Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Sustained Release Excipients Market

  • 20.1. Spain Sustained Release Excipients Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Sustained Release Excipients Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Sustained Release Excipients Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Sustained Release Excipients Market

  • 21.1. Eastern Europe Sustained Release Excipients Market Overview
  • 21.2. Eastern Europe Sustained Release Excipients Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Sustained Release Excipients Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Sustained Release Excipients Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Sustained Release Excipients Market

  • 22.1. Russia Sustained Release Excipients Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Sustained Release Excipients Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Sustained Release Excipients Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Sustained Release Excipients Market

  • 23.1. North America Sustained Release Excipients Market Overview
  • 23.2. North America Sustained Release Excipients Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Sustained Release Excipients Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Sustained Release Excipients Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Sustained Release Excipients Market

  • 24.1. USA Sustained Release Excipients Market Overview
  • 24.2. USA Sustained Release Excipients Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Sustained Release Excipients Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Sustained Release Excipients Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Sustained Release Excipients Market

  • 25.1. Canada Sustained Release Excipients Market Overview
  • 25.2. Canada Sustained Release Excipients Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Sustained Release Excipients Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Sustained Release Excipients Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Sustained Release Excipients Market

  • 26.1. South America Sustained Release Excipients Market Overview
  • 26.2. South America Sustained Release Excipients Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Sustained Release Excipients Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Sustained Release Excipients Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Sustained Release Excipients Market

  • 27.1. Brazil Sustained Release Excipients Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Sustained Release Excipients Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Sustained Release Excipients Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Sustained Release Excipients Market

  • 28.1. Middle East Sustained Release Excipients Market Overview
  • 28.2. Middle East Sustained Release Excipients Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Sustained Release Excipients Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Sustained Release Excipients Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Sustained Release Excipients Market

  • 29.1. Africa Sustained Release Excipients Market Overview
  • 29.2. Africa Sustained Release Excipients Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Sustained Release Excipients Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Sustained Release Excipients Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Sustained Release Excipients Market Competitive Landscape And Company Profiles

  • 30.1. Sustained Release Excipients Market Competitive Landscape
  • 30.2. Sustained Release Excipients Market Company Profiles
    • 30.2.1. Mylan N.V.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Pfizer Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Sun Pharmaceutical Industries Ltd.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Novartis AG
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Ashland Global Holdings
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Sustained Release Excipients Market Competitive Benchmarking

32. Global Sustained Release Excipients Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Sustained Release Excipients Market

34. Sustained Release Excipients Market Future Outlook and Potential Analysis

  • 34.1 Sustained Release Excipients Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Sustained Release Excipients Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Sustained Release Excipients Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer